Saquib Rahim, MD, MBA

Led clinical and product strategy for LG Electronics' health tech subsidiary, securing a partnership with the state of West Virginia, including all major health systems and a pilot with Marshall Health.

Pioneered the development and launch of AI-enabled chronic care pilots for LG Electronics, with an initial focus on obesity-related disease, projected for 2025.

Provided expert healthcare subject matter consultation for tech and data-oriented projects across diverse healthcare verticals for LEK Consulting.

Headed clinical innovation for SimpleHealthKit, a Kleiner-backed startup, developing a comprehensive at-home lab testing platform for multiple chronic conditions and securing partnerships with Amazon, Walmart, and multiple payers.

Developed an ontology framework for HumanFirst's core digital health-focused clinical trials platform, leading to its acquisition by ICON in February 2024.

Established a tripartite partnership among Google, Deloitte, and Merck, leading a 20+ person team to apply AI and remote sensing technology for patient identification and stratification in Pulmonary and Oncology, delivering an 85% accurate prototype endorsed by senior leadership.

Authored corporate strategy presentations for C-level executives at Merck, highlighting digital health and analytics growth in pharma and shaping commercial operating plans.

Conceptualized and designed a new product for CipherHealth to improve surgical cycle performance, successfully securing a pilot customer.

Led a team of 40+ clinicians (MDs/NPs/PAs) at Tenet Healthcare to optimize cross-department operations, redesigning the Observation Unit to achieve a 33% reduction in Length of Stay (LOS) and a 50% decrease in readmissions.

Spearheaded the development and implementation of Real-World Evidence (RWE) use cases, informing asset development, trial design, and go/no-go decisions across 10+ programs spanning 30M+ patients globally, with a $2B+ total trial budget and $6B+ in potential annual recurring revenue.

Headed data science efforts for all business development pursuits spanning 6 assets in 2022, driving strategic decisions.

Managed a cross-functional team applying Artificial Intelligence (AI) to quantify static and dynamic imaging, delivering a 90%+ accurate proof of concept for endoscopy, and co-authored government briefing books on AI in imaging.

Cultivated key partnerships with UCSF and University of Michigan, co-authoring a published manuscript on external control arms via EHR data and contributing to AI-enabled novel endpoints presented at the 2022 Digestive Disease Week conference, advancing TA core data science strategy.

Created the core company strategy and business model, integrating market research, sales force optimization, and digital engagement into a commercial platform to better connect patients with appropriate therapy.

Sourced and led partnership discussions with large-cap pharma on established, underpenetrated assets, developing a scalable model for future business development efforts.

Launched the AetnaHealth tech platform, achieving a 10-point increase in persistent member engagement and Net Promoter Score (NPS), and defining the strategy, product roadmap, and implementation for digital transformation.

Architected the Next Best Action personalized health action program, generating $11.2M in attributable cost savings in the first year through use cases including medication adherence, care steerage, and preventative screenings.

Led clinical strategy and operations for a partnership with Apple, combining wearable tech, analytics, and incentives to launch a successful pilot reaching 1M members across commercial and self-insured business lines.

Sourced and secured a strategic deal with Sutter Health, an $11B+ annual revenue northern California health system.

Led product launch in the greater Boston market, forming local practitioner and behavioral health networks.